tiprankstipranks
Blurbs

Analysts Are Bullish on Top Healthcare Stocks: HCA Healthcare (HCA), Gossamer Bio (GOSS)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on HCA Healthcare (HCAResearch Report) and Gossamer Bio (GOSSResearch Report) with bullish sentiments.

HCA Healthcare (HCA)

In a report released today, John Ransom from Raymond James maintained a Buy rating on HCA Healthcare, with a price target of $245.00. The company’s shares closed last Monday at $210.50.

According to TipRanks.com, Ransom is a 5-star analyst with an average return of 10.2% and a 58.3% success rate. Ransom covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, UnitedHealth, and Amedisys.

HCA Healthcare has an analyst consensus of Strong Buy, with a price target consensus of $260.13, a 24.8% upside from current levels. In a report released yesterday, Cowen & Co. also maintained a Buy rating on the stock with a $241.00 price target.

See the top stocks recommended by analysts >>

Gossamer Bio (GOSS)

In a report released today, Steven Seedhouse from Raymond James maintained a Buy rating on Gossamer Bio, with a price target of $10.00. The company’s shares closed last Monday at $9.08.

According to TipRanks.com, Seedhouse is a 3-star analyst with an average return of 2.1% and a 39.9% success rate. Seedhouse covers the Healthcare sector, focusing on stocks such as Apellis Pharmaceuticals, NGM Biopharmaceuticals, and Arcturus Therapeutics.

Gossamer Bio has an analyst consensus of Strong Buy, with a price target consensus of $15.33, which is a 93.3% upside from current levels. In a report released yesterday, Piper Sandler also maintained a Buy rating on the stock with a $15.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on HCA:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed